Schonfeld Strategic Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Sell |
145,282
-436,464
| -75% | -$4.93M | 0.01% | 1004 |
|
|
2025
Q1 | $6.71M | Buy |
+581,746
| New | +$6.71M | 0.04% | 387 |
|
|
2024
Q2 | – | Sell |
-12,800
| Closed | -$152K | – | 2173 |
|
|
2024
Q1 | $152K | Buy |
+12,800
| New | +$152K | ﹤0.01% | 1623 |
|
|
2019
Q4 | – | Sell |
-40,600
| Closed | -$471K | – | 1360 |
|
|
2019
Q3 | $471K | Sell |
40,600
-65,800
| -62% | -$763K | 0.01% | 662 |
|
|
2019
Q2 | $2.36M | Buy |
106,400
+95,400
| +867% | +$2.11M | 0.08% | 260 |
|
|
2019
Q1 | $315K | Buy |
+11,000
| New | +$315K | 0.01% | 821 |
|